162 related articles for article (PubMed ID: 7884509)
1. Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.
Ohtake T; Yokoyama I; Watanabe T; Momose T; Serezawa T; Nishikawa J; Sasaki Y
J Nucl Med; 1995 Mar; 36(3):456-63. PubMed ID: 7884509
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
3. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
4. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA
Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
[TBL] [Abstract][Full Text] [Related]
5. Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET.
Nishikawa J; Ohtake T; Yokoyama I; Watanabe T; Momose T; Sasaki Y
Ann Nucl Med; 1996 Aug; 10(3):323-8. PubMed ID: 8883708
[TBL] [Abstract][Full Text] [Related]
6. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
7. Delayed enhancement of myocardial FDG uptake on glucose loading FDG-PET in NIDDM patient.
Tsuchida T; Yonekura Y; Wada Y; Sadato N; Yamamoto K; Waki A; Nakano A; Lee JD; Hayashi N; Ishii Y
Ann Nucl Med; 1997 Nov; 11(4):331-4. PubMed ID: 9460526
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
[TBL] [Abstract][Full Text] [Related]
10. Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease.
Mäki M; Nuutila P; Laine H; Voipio-Pulkki LM; Haaparanta M; Solin O; Knuuti JM
Diabetes; 1997 Sep; 46(9):1491-6. PubMed ID: 9287051
[TBL] [Abstract][Full Text] [Related]
11. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
[TBL] [Abstract][Full Text] [Related]
12. Effect of nicotinic acid on exogenous myocardial glucose utilization.
Stone CK; Holden JE; Stanley W; Perlman SB
J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
[TBL] [Abstract][Full Text] [Related]
13. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
14. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
[TBL] [Abstract][Full Text] [Related]
15. Simplified PET quantitation of myocardial glucose utilization.
Nakagawa K; Namba H; Iyo M; Fukushi K; Irie T; Yamanouchi M; Shikama N; Himi T; Yoshida K; Masuda Y
J Nucl Med; 1995 Nov; 36(11):2094-102. PubMed ID: 7472605
[TBL] [Abstract][Full Text] [Related]
16. Myocardial 18F-FDG-PET. Experiences with the euglycemic hyperinsulinemic clamp technique.
Locher JT; Frey LD; Seybold K; Jenzer H
Angiology; 1995 Apr; 46(4):313-20. PubMed ID: 7726451
[TBL] [Abstract][Full Text] [Related]
17. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus.
Hattori N; Tamaki N; Kudoh T; Masuda I; Magata Y; Kitano H; Inubushi M; Tadamura E; Nakao K; Konishi J
J Nucl Med; 1998 Nov; 39(11):1835-40. PubMed ID: 9829566
[TBL] [Abstract][Full Text] [Related]
18. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
[TBL] [Abstract][Full Text] [Related]
19. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.
Berry JJ; Baker JA; Pieper KS; Hanson MW; Hoffman JM; Coleman RE
J Nucl Med; 1991 Aug; 32(8):1518-25. PubMed ID: 1869972
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
